CheckMyRecalls

10,013 recalls · updated 20 Nov 2026

Sandoz Inc recalls Cefazolin for Injection and 1 more

Read the official FDA notice

Published
9 Jul 2025
Units affected
2 products
Agency
FDA
Country
United States

The hazard

Labeling: Label Mix-Up; cartons of Cefazolin for Injection, USP 1 gram were found to contain vials labeled as penicillin G potassium for Injection, USP, 20 million Unit. The vials contained Cefozalin

Classification: Class I — the most serious type: there is a reasonable chance this product could cause serious health problems or death.

What to do

Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.

  • Check the lot number on the box or bottle.
  • Talk to your pharmacist or doctor before stopping any prescribed medicine.
  • Return the product to the pharmacy for safe disposal.
Read the official FDA notice

Product details

Cefazolin for Injection, USP, 1 gram per vial, Sterile, For Intramuscular or Intravenous Use, Rx Only, Manufactured by Sandoz GmbH for Sandoz Inc. Princeton, NJ 08540, NDC: 0781 3451-70 (vial), NDC: 0781-3451-96 (carton).

Buffered Penicillin G Potassium for Injection, USP 20,000,000 Units (20 million units), For IV use, Sterile, Rx Only, Manufactured in Austria by Sandoz GmbH for Sandoz Inc. Princeton, NJ 08540, NDC: 0781-6136-94.

Brand / company
Sandoz Inc
Codes / lots
Lot # PG4360, PG4362, Exp. 11/30/2027 | Lot # PG4360, PG4362, Exp. 11/30/2027
Distribution
Nationwide in the USA
Recall status
Ongoing

Source: U.S. Food and Drug Administration, published 9 Jul 2025. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.